On Tuesday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) opened higher 3.52% from the last session, before settling in for the closing price of $5.96. Price fluctuations for OLMA have ranged from $4.60 to $16.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -7.49% at the time writing. With a float of $53.76 million, this company’s outstanding shares have now reached $57.29 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Olema Pharmaceuticals Inc is 21.33%, while institutional ownership is 70.84%. The most recent insider transaction that took place on Jan 08 ’25, was worth 1,727,370. In this transaction 10% Owner of this company bought 300,000 shares at a rate of $5.76, taking the stock ownership to the 7,800,000 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Director sold 700,761 for $6.75, making the entire transaction worth $4,730,137. This insider now owns 0 shares in total.
Olema Pharmaceuticals Inc (OLMA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.34% during the next five years compared to -105.28% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Check out the current performance indicators for Olema Pharmaceuticals Inc (OLMA). In the past quarter, the stock posted a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
The latest stats from [Olema Pharmaceuticals Inc, OLMA] show that its last 5-days average volume of 1.23 million was inferior to 1.31 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.21%. Additionally, its Average True Range was 0.52.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 16.83%, which indicates a significant decrease from 69.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.36% in the past 14 days, which was lower than the 81.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.96, while its 200-day Moving Average is $10.62. Now, the first resistance to watch is $6.33. This is followed by the second major resistance level at $6.50. The third major resistance level sits at $6.75. If the price goes on to break the first support level at $5.91, it is likely to go to the next support level at $5.66. Assuming the price breaks the second support level, the third support level stands at $5.49.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are currently 57,298K shares outstanding in the company with a market cap of 421.61 million. Presently, the company’s annual sales total 0 K according to its annual income of -96,660 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -34,560 K.
